PFIZER, BIONTECH TO APPLY FOR FULL US REGULATORY APPROVAL FOR THEIR COVID-19 VACCINE

Highlights

• Pfizer and BioNTech in a press release on Friday said they plan to submit data backing the application on a rolling basis over the coming weeks to the Food and Drug Administration (FDA). 

• Pfizer Chief Executive Albert Bourla said “We are proud of the tremendous progress we've made since December in delivering vaccines to millions of Americans, in collaboration with the US government.&....